Japan - HealthQuill

https://www.merck.com/product/usa/pi_circulars/g/gardasil_9/gardasil_9_ppi.pdf

Merck meets main goal during end-stage trial of HPV vaccine in Japan

Merck & Co., announced it has met its primary and secondary goals during the end-stage trials of its human papillomavirus (HPV) vaccine in.

by HealthQuill
September 11, 2024
0 Comments

China’s drug regulator, the National Medical Products Association, has approved AstraZeneca Plc’s asthma drug.

Drugs Health Pharma

AstraZeneca’s asthma drug gets regulator’s approval in China

China’s drug regulator, the National Medical Products Association, has approved AstraZeneca Plc’s asthma drug.

by HealthQuill
August 20, 2024
0 Comments

https://www.merck.com/news/daiichi-sankyo-and-merck-enter-into-global-development-and-commercialization-agreement-for-mk-6070/

Drugs Health Pharma

Daiichi Sankyo to pay Merck $170 million for cancer test drug rights

Daiichi Sankyo will pay Merck & Co. Inc., $170 million upfront to bag commercialization and development rights of the latter’s test drug for.

by HealthQuill
August 6, 2024
0 Comments

Japanese researchers have developed a non-invasive alternative to detect human papillomavirus by testing urine samples, a discovery that may transform cervical cancer screening.

Drugs Health Pharma

Urine tests can detect cervical cancer viruses, make screening easy

Japanese researchers have developed a non-invasive alternative to detect human papillomavirus by testing urine samples, a discovery that may transform cervical cancer screening.

by HealthQuill
July 17, 2024
0 Comments

AstraZeneca, Daiichi’s breast cancer drug trial results show improvement in progression-free survival

Drugs Health Pharma

AstraZeneca, Daiichi’s breast cancer drug trials show rise in survival

HQ Team June 3, 2024: An antibody-drug conjugate, jointly being developed by AstraZeneca and Daiichi Sankyo, has been shown in end-stage clinical trials.

by HealthQuill
June 3, 2024
0 Comments

Japan’s Eisai Co., and US-based Biogen Inc., announced its Leqembi injection will be sold in Japan from Japan from December 20, the second country after the US.

Drugs Health Pharma

Eisai, Biogen to sell Alzheimer’s drug in Japan starting December 20

HQ Team December 13, 2023: Japan’s Eisai Co., and US-based Biogen Inc., announced its Leqembi injection will be sold in Japan from Japan.

by HealthQuill
December 13, 2023
0 Comments

Record-breaking heatwaves have impacted agricultural production in Japan and the East Asian nation may look at imports to meet supply shortfalls.

Climate Health Pharma

Heatwaves in Japan hit agricultural output, may opt for imports

HQ Team September 25, 2023: Record-breaking heatwaves have impacted agricultural production in Japan and the East Asian nation may look at imports to.

by HealthQuill
September 25, 2023
0 Comments

Eisai Co., and Biogen Inc., announced that their drug to treat Alzheimer’s disease and cognitive impairment has been approved in Japan.

Drugs Health Pharma

Japan approves Eisai Co, Biogen Inc’s Leqembi for Alzheimer’s

HQ Team September 25, 2023: Eisai Co., and Biogen Inc., announced that their drug to treat Alzheimer’s disease and cognitive impairment has been.

by HealthQuill
September 25, 2023
0 Comments

The European Commission granted Pfizer Inc., a marketing authorisation for its once-daily oral capsule to treat hair loss or alopecia aerate.

Drugs Health Pharma

Pfizer’s oral capsule Litfulo to treat hair loss gets EU approval

HQ Team September 19, 2023: The European Commission granted Pfizer Inc., a marketing authorisation for its once-daily oral capsule to treat hair loss.